Published in Acta Med Scand on October 01, 1973
Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol (1981) 1.34
B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. Clin Exp Immunol (1983) 1.22
Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol (1978) 1.10
Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes. Ann Surg (1999) 0.94
The primary immune response in patients with selective IgA deficiency. Clin Exp Immunol (1983) 0.90
Factors influencing the secondary antibody response to flagellin in man. Clin Exp Immunol (1978) 0.85
Primary immune response to Helix pomatia haemocyanin in malignant melanoma. Relationship between 19S and 7S antibody response and in vitro lymphocyte transformation. Clin Exp Immunol (1976) 0.83
Do food antigens play a role in the pathogenesis of some cases of human glomerulonephritis? Clin Exp Immunol (1983) 0.83
The primary immune response of patients with different stages of squamous-cell bronchial carcinoma. Thorax (1978) 0.79
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol (1988) 4.05
Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol (1988) 3.76
Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method. Immunology (1970) 3.09
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol (1995) 2.66
Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. Clin Exp Immunol (1974) 2.57
Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation. Immunology (1970) 2.56
Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum (1990) 2.24
Demonstration of IgM cytomegalovirus-antibodies as an aid to early diagnosis in adults. Clin Exp Immunol (1970) 2.24
Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients. Transplantation (1989) 2.20
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (2000) 2.19
Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis (1995) 2.16
Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet (1990) 2.12
Use of PCR with feces for detection of Helicobacter pylori infections in patients. J Clin Microbiol (1994) 2.09
Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int (1990) 1.77
Functional studies on lymphocytes in adult human bone marrow. II. Isolated surface IgM-positive cells. J Immunol (1979) 1.70
Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients. J Neurol Sci (1983) 1.69
The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol (1992) 1.67
Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 1.64
Sensitivity of culture compared with that of polymerase chain reaction for detection of Helicobacter pylori from antral biopsy samples. J Clin Microbiol (1993) 1.62
Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis (1993) 1.62
Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization. Am J Dis Child (1993) 1.61
Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology (2000) 1.60
Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis (1991) 1.59
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Trop Med Int Health (2001) 1.51
Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. Clin Exp Immunol (1977) 1.49
Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine (1997) 1.44
Rapid detection of infectious cytomegalovirus in blood with the aid of monoclonal antibodies. J Med Virol (1987) 1.42
Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis (1982) 1.39
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood (1994) 1.39
Cytomegalovirus antigenemia assay. J Clin Microbiol (1991) 1.39
Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis (1996) 1.35
Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol (1981) 1.34
Antibodies against membrane antigens of cytomegalovirus infected cells in sera of patients with a cytomegalovirus infection. Clin Exp Immunol (1972) 1.34
Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med (1992) 1.33
Acetylsalicylic acid as a cause of pancytopenia from bone-marrow damage. Lancet (1966) 1.33
Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol (1993) 1.33
Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection. J Gen Virol (1994) 1.30
Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol (1994) 1.29
Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. Am J Med (1980) 1.28
Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res (1985) 1.28
Immune-complex glomerulopathy in patients treated with captopril. Lancet (1980) 1.23
Acute cytomegalovirus infection and the host immune response. I. Development and maintenance of cytomegalovirus (CMV) induced in vitro lymphocyte reactivity and its relationship to the production of CMV antibodies. Clin Exp Immunol (1980) 1.22
Phase I clinical and pharmacologic study of chronic oral administration of the farnesyl protein transferase inhibitor R115777 in advanced cancer. J Clin Oncol (2002) 1.22
B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. Clin Exp Immunol (1983) 1.22
Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen. Br Med J (1973) 1.16
Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection. Clin Exp Immunol (1990) 1.16
Lymphocyte 5'-nucleotidase in primary hypogammaglobulinaemia and cord blood. Clin Exp Immunol (1980) 1.14
Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol (1990) 1.14
Cytomegalovirus (CMV) antigenemia: rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients. Transplant Proc (1989) 1.13
The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection. J Clin Microbiol (1995) 1.12
Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med (1993) 1.11
Direct visualisation and quantification of cellular cytotoxicity using two colour flourescence. J Immunol Methods (1992) 1.11
Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. Cancer Res (1985) 1.11
Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med (1991) 1.11
A standrard method for DNCB sensitization testing in patients with neoplasms. Cancer (1974) 1.11
Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol (1978) 1.10
Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test. Clin Exp Immunol (1977) 1.10
Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon. J Rheumatol (1983) 1.09
In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother (1994) 1.08
Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera. Lack of tumor-specific reactions on melanoma lines. Ann N Y Acad Sci (1975) 1.08
Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology (1990) 1.08
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin Exp Immunol (1985) 1.07
Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? Clin Exp Immunol (1984) 1.07
Cytomegalovirus hepatitis in normal and immune compromised hosts. Liver (1984) 1.07
Is cytomegalovirus infection a major cause of T cell alterations after (autologous) bone-marrow transplantation? Lancet (1984) 1.07
Increased intestinal permeability during cytomegalovirus infection in renal transplant recipients. Transpl Int (1996) 1.07
Pneumococcal capsular antigen detection and pneumococcal serology in patients with community acquired pneumonia. Thorax (1991) 1.06
Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation. Transpl Int (1989) 1.05
Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response. J Hepatol (1989) 1.04
Acute cytomegalovirus infection and the host immune response. II. Relationship of suppressed in vitro lymphocyte reactivity to bacterial recall antigens and mitogens with the development of cytomegalovirus-induced lymphocyte reactivity. Clin Exp Immunol (1980) 1.04
The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity. Clin Exp Immunol (1987) 1.03
Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics (1989) 1.03
Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood (1997) 1.03
The role of antigen detection in pneumococcal carriers: a comparison between cultures and capsular antigen detection in upper respiratory tract secretions. Scand J Infect Dis (1993) 1.02
The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. Neth J Med (1999) 1.02
Human fibroblasts, a convenient nuclear substrate for detection of anti-nuclear antibodies including anti-centromere antibodies. Scand J Rheumatol (1983) 1.01
Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test. J Clin Microbiol (1992) 1.01
Cytomegalovirus antigenemia assay: identification of the viral antigen as the lower matrix protein pp65. J Infect Dis (1992) 1.01
Minimum number of pneumococci required for capsular antigen to be detectable by latex agglutination. J Clin Microbiol (1992) 1.00
Low HLA-DR expression on monocytes as a prognostic marker for bacterial sepsis after liver transplantation. Transplantation (1997) 1.00
An improved immunocytochemical method for the detection of human cytomegalovirus antigens in peripheral blood leucocytes. Histochemistry (1989) 1.00
Associated expression of CD1 antigen and Fc receptor for IgE on epidermal Langerhans cells from patients with atopic dermatitis. Clin Exp Immunol (1988) 1.00
Cryopreservation of newly formed hybridomas. J Immunol Methods (1983) 1.00
Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis. Clin Exp Immunol (1987) 0.99
Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma. Thorax (1977) 0.99
Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol (1998) 0.99
The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ. Eur Urol (2002) 0.99
IgM-anti-HBc as a marker of persistent and IgG-anti-HBc as a marker of past hepatitis B infection. A longitudinal study over 5 years. Acta Hepatogastroenterol (Stuttg) (1978) 0.98
Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma. Thorax (1980) 0.98
Penicillin concentrations in cerebrospinal fluid (CSF) during repository treatment regimen for syphilis. Genitourin Med (1988) 0.98
Identification of three indolic compounds in a pigmented-melanoma cell-culture supernatant by gas chromatography-mass spectrometry. J Cancer Res Clin Oncol (1983) 0.98
Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients. Clin Exp Immunol (1978) 0.98